secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2025-08-15T23:59:59+00:00
Accession:  0000950170-25-109139
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCW Biologics amends $20M equity line to allow intraday share sales to Square Gate Capital
--------------------------------------------------------------------------------

- First Amendment to $20M Equity Purchase Agreement with Square Gate Capital allows multiple intraday share purchases on same trading day.
- Intraday Put Shares priced at 100% of lowest trade price during shortened valuation period after Transfer Agent confirms DWAC.
- Company may submit additional put notices only after prior shares' DWAC confirmed; investor must accept within 30 minutes.
- Total commitment remains $20M over 36 months; no other changes to original February 2025 terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000095017025109139/0000950170-25-109139-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000095017025109139/hcwb-20250814.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-109139

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer